Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030332142> ?p ?o ?g. }
- W2030332142 endingPage "458" @default.
- W2030332142 startingPage "449" @default.
- W2030332142 abstract "(R)-3-(1-[2-(4-benzoyl-2-(3,4-difluorophenyl)-morpholin-2-yl)- ethyl]-4-phenylpiperidin-4-yl)-1-dimethylurea (SR 144190) is a new non-peptide antagonist of tachykinin NK2 receptors. SR 144190 potently and selectively inhibited neurokinin A binding to NK2 receptors from various species, including humans. In in vitro functional assays, it was a potent, selective and competitive antagonist of NK2 receptors with apparent affinities (pA2 values) between 9.08 and 10.10. In vivo, SR 144190 blocked [Nle10]neurokinin A-(4-10)-induced bronchoconstriction in guinea pigs (ID50 = 21 micrograms kg-1 i.v. and 250 micrograms kg-1 i.d.) and [beta Ala8]neurokinin A-(4-10)-induced urinary bladder contraction in rats (ID50 = 11 micrograms kg-1 i.v. and 190 micrograms kg-1 i.d.). It prevented citric acid-induced cough and airway hyperresponsiveness to acetylcholine in guinea pigs (1 mg kg-1 i.p.) as well as castor oil-induced diarrhoea in rats (0.01-10 micrograms kg-1 s.c. or p.o). Finally, it blocked the turning behaviour induced by intrastriatal injections of [Nle10]neurokinin A-(4-10) in mice (ID50 = 3 micrograms kg-1 i.v. and 16 micrograms kg-1 p.o.)." @default.
- W2030332142 created "2016-06-24" @default.
- W2030332142 creator A5003380039 @default.
- W2030332142 creator A5008369945 @default.
- W2030332142 creator A5014412277 @default.
- W2030332142 creator A5015174277 @default.
- W2030332142 creator A5021666996 @default.
- W2030332142 creator A5031269524 @default.
- W2030332142 creator A5035215054 @default.
- W2030332142 creator A5038289988 @default.
- W2030332142 creator A5054006224 @default.
- W2030332142 creator A5056250454 @default.
- W2030332142 creator A5056591563 @default.
- W2030332142 creator A5069946536 @default.
- W2030332142 creator A5073079789 @default.
- W2030332142 creator A5079640130 @default.
- W2030332142 creator A5083022146 @default.
- W2030332142 creator A5086017213 @default.
- W2030332142 creator A5089045705 @default.
- W2030332142 date "1997-10-01" @default.
- W2030332142 modified "2023-10-18" @default.
- W2030332142 title "Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist" @default.
- W2030332142 cites W1978707089 @default.
- W2030332142 cites W1988590403 @default.
- W2030332142 cites W1995390092 @default.
- W2030332142 cites W2009463707 @default.
- W2030332142 cites W2016004241 @default.
- W2030332142 cites W2021433535 @default.
- W2030332142 cites W2023800668 @default.
- W2030332142 cites W2027396764 @default.
- W2030332142 cites W2027529370 @default.
- W2030332142 cites W2029480781 @default.
- W2030332142 cites W2038169694 @default.
- W2030332142 cites W2049489857 @default.
- W2030332142 cites W2052954603 @default.
- W2030332142 cites W2053583807 @default.
- W2030332142 cites W2054077502 @default.
- W2030332142 cites W2055004459 @default.
- W2030332142 cites W2057971042 @default.
- W2030332142 cites W2058895823 @default.
- W2030332142 cites W2064385634 @default.
- W2030332142 cites W2073557461 @default.
- W2030332142 cites W2077714000 @default.
- W2030332142 cites W2080761218 @default.
- W2030332142 cites W2087698910 @default.
- W2030332142 cites W2089546084 @default.
- W2030332142 cites W2091303128 @default.
- W2030332142 cites W2093894797 @default.
- W2030332142 cites W2111367792 @default.
- W2030332142 cites W2161498398 @default.
- W2030332142 cites W2169715944 @default.
- W2030332142 cites W2170651949 @default.
- W2030332142 cites W4205460479 @default.
- W2030332142 doi "https://doi.org/10.1016/s0143-4179(97)90039-1" @default.
- W2030332142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9413022" @default.
- W2030332142 hasPublicationYear "1997" @default.
- W2030332142 type Work @default.
- W2030332142 sameAs 2030332142 @default.
- W2030332142 citedByCount "39" @default.
- W2030332142 countsByYear W20303321422012 @default.
- W2030332142 countsByYear W20303321422013 @default.
- W2030332142 countsByYear W20303321422014 @default.
- W2030332142 countsByYear W20303321422016 @default.
- W2030332142 countsByYear W20303321422020 @default.
- W2030332142 crossrefType "journal-article" @default.
- W2030332142 hasAuthorship W2030332142A5003380039 @default.
- W2030332142 hasAuthorship W2030332142A5008369945 @default.
- W2030332142 hasAuthorship W2030332142A5014412277 @default.
- W2030332142 hasAuthorship W2030332142A5015174277 @default.
- W2030332142 hasAuthorship W2030332142A5021666996 @default.
- W2030332142 hasAuthorship W2030332142A5031269524 @default.
- W2030332142 hasAuthorship W2030332142A5035215054 @default.
- W2030332142 hasAuthorship W2030332142A5038289988 @default.
- W2030332142 hasAuthorship W2030332142A5054006224 @default.
- W2030332142 hasAuthorship W2030332142A5056250454 @default.
- W2030332142 hasAuthorship W2030332142A5056591563 @default.
- W2030332142 hasAuthorship W2030332142A5069946536 @default.
- W2030332142 hasAuthorship W2030332142A5073079789 @default.
- W2030332142 hasAuthorship W2030332142A5079640130 @default.
- W2030332142 hasAuthorship W2030332142A5083022146 @default.
- W2030332142 hasAuthorship W2030332142A5086017213 @default.
- W2030332142 hasAuthorship W2030332142A5089045705 @default.
- W2030332142 hasConcept C118303440 @default.
- W2030332142 hasConcept C126322002 @default.
- W2030332142 hasConcept C134018914 @default.
- W2030332142 hasConcept C170493617 @default.
- W2030332142 hasConcept C185592680 @default.
- W2030332142 hasConcept C2776042228 @default.
- W2030332142 hasConcept C2776533618 @default.
- W2030332142 hasConcept C2776885963 @default.
- W2030332142 hasConcept C2777056410 @default.
- W2030332142 hasConcept C2778122271 @default.
- W2030332142 hasConcept C2778815084 @default.
- W2030332142 hasConcept C2780769369 @default.
- W2030332142 hasConcept C2781359426 @default.
- W2030332142 hasConcept C55493867 @default.
- W2030332142 hasConcept C55938493 @default.
- W2030332142 hasConcept C71924100 @default.